Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
Sponsor: Walter Reed National Military Medical Center
Summary
This protocol studies the clinical outcome of patients with active thyroid disease with visually significant signs and symptoms of proptosis, pain, diplopiam lid/orbital edema, or lid/orbital erythema recommended for treatment with teprotumumab infusion (Tepezza®). Patients recommended for treatment will be evaluated by an oculoplastic surgeon (Dr. Eva Chou) and endocrinologist (Dr. Thanh Hoang).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2021-05-12
Completion Date
2027-12-12
Last Updated
2024-02-23
Healthy Volunteers
Yes
Interventions
Teprotumumab Injection [Tepezza]
IGF1 monoclonal antibody
Locations (1)
Walter Reed National Military Medical Center
Bethesda, Maryland, United States